InnoCan Pharma (InnoCan Pharma) Price-to-Tangible-Book : 13.30 (As of May. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Price-to-Tangible-Book?

As of today (2024-05-15), InnoCan Pharma's share price is $0.1995. InnoCan Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.02. Hence, InnoCan Pharma's Price to Tangible Book Ratio of today is 13.30.

The historical rank and industry rank for InnoCan Pharma's Price-to-Tangible-Book or its related term are showing as below:

INNPF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.14 Med: 13.54 Max: 19.95
Current: 19.95

During the past 6 years, InnoCan Pharma's highest Price to Tangible Book Ratio was 19.95. The lowest was 6.14. And the median was 13.54.

INNPF's Price-to-Tangible-Book is ranked worse than
93.08% of 867 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs INNPF: 19.95

A closely related ratio is called PB Ratio. As of today, InnoCan Pharma's share price is $0.1995. InnoCan Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.02. Hence, InnoCan Pharma's P/B Ratio of today is 13.30.

InnoCan Pharma Price-to-Tangible-Book Historical Data

The historical data trend for InnoCan Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Price-to-Tangible-Book Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

17.74

8.27

20.00

InnoCan Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															8.27	8.60	9.69	13.96	20.00

Competitive Comparison of InnoCan Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, InnoCan Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnoCan Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InnoCan Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where InnoCan Pharma's Price-to-Tangible-Book falls into.

InnoCan Pharma Price-to-Tangible-Book Calculation

InnoCan Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.1995	/	0.015
	=	13.30

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

InnoCan Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (InnoCan Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.